Volume 10, Issue 4 (8-2012)                   IJRM 2012, 10(4): 321-328 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khanaki K, Motavalizadeh Ardekani A, Ghassemzadeh A, Shahnazi V, Sadeghi M R, Darabi M, et al . Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells. IJRM 2012; 10 (4) :321-328
URL: http://ijrm.ir/article-1-297-en.html
1- Department of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran- Iran
3- Women’s Reproductive Health Research Center, Alzahra Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
4- Sarem Cell Research Center (SCRC), Sarem Women's Hospital, Tehran, Iran
5- Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6- Department of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran , rahimipour.ali@gmail.com
Abstract:   (2725 Views)
Background: Endometriosis is a common chronic inflammation which leads to infertility and chronic pelvic pain in affected women. Secretory phospholipase A2 type IIa (sPLA2IIa) is an acute phase reactant that is markedly increased in inflammatory disorders.
Objective: To assess the effects of ω-3 and ω-6 polyunsaturated fatty acids (PUFAs) administration in endometrial cells culture on sPLA2IIa level and cell survival comparing homolog ectopic versus eutopic endometrial cells from endometriosis patients.
Materials and Methods: In this experimental study, ectopic and eutopic endometrial tissue samples obtained from 15 endometriosis patients were immediately frozen. After thawing and tissue digestion, mixed stromal and endometrial gland cells were cultured for 8 days in three different culture media; balanced ω-3/ω-6, high ω-3 and high ω-6 PUFAs ratio. Cell survival was measured using 2, 3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-(phenylamino) carbonyl-2H- tetrazolium hydroxide (XTT) method and sPLA2IIa level assessed with ELISA technique.
Results: The sPLA2IIa level was significantly higher in the ectopic endometrial cell culture compared to the eutopic group for each of the three matched treatments (balanced, high ω-3 and high ω-6). Also the sPLA2IIa level in the ectopic endometrial cell group was remarkably increased by each of the three PUFAs treatments compared to control condition (p<0.05, p<0.01, p<0.05 respectively). Cell survival in the eutopic group was significantly decreased by high ω-6 culturing compared to control medium (p<0.05).
Conclusion: The increase in sPLA2IIa level in ectopic endometrial cells by fatty acid treatments (especially high ω-3), strengthens the hypothesis that PUFAs stimulate secretion of cytokines leading to increased sPLA2IIa level.
Full-Text [PDF 470 kb]   (636 Downloads) |   |   Full-Text (HTML)  (295 Views)  
Type of Study: Original Article |

References
1. Strathy JH, Molgaard CA, Coulman CB. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 1982; 38: 667-672. [DOI:10.1016/S0015-0282(16)46691-4]
2. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-1799. [DOI:10.1016/S0140-6736(04)17403-5]
3. Ulukus M, Arici A. Immunology of endometriosis. Minerva Gynecol 2005; 57: 237-248.
4. Chang CY, Chang HW, Chen CM, Lin CY, Chen CP, Lai CH, et al. MUC4 gene polymorphisms associate with endometriosis development and endometriosis related infertility. BMC Medicine 2011; 9: 19. [DOI:10.1186/1741-7015-9-19]
5. Koike H, Egawa H, Ohtsuka T, Yamaguchi M, Ikenoue T, Mori N. Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins Leukot Essent Fatty Acids 1992; 46: 133-137. [DOI:10.1016/0952-3278(92)90219-9]
6. Harada R, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001; 76: 1-10. [DOI:10.1016/S0015-0282(01)01816-7]
7. Wu M, Shoji Y, Chuang P, Tsai S. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 2007; 9: 1-20. [DOI:10.1017/S146239940700021X]
8. Lousse JC, Defre`re S, Gonza´lez Ramos R, Van Langendonckt A, Colette S, Donnez J. Involvement of iron, nuclear factor-kappa B (NF-kB) and prostaglandins in the pathogenesis of peritoneal endometriosis associated inflammation: a review. J Endometr 2009; 1: 19-29. [DOI:10.1177/228402650900100104]
9. Banu SK, Lee J, Speights VO, Starzinski-Powitz A, Arosh JA. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 2008; 149: 1180-1189. [DOI:10.1210/en.2007-1168]
10. Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M, et al. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 2008; 23: 2701-2708. [DOI:10.1093/humrep/den315]
11. Gazvani MR, Smith L, Haggarty P, Fowler PA, Templeton A. High omega-3: omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis. Fertil Steril 2001; 76: 717-722. [DOI:10.1016/S0015-0282(01)01991-4]
12. Sesti F, Pietropolli A, Capozzolo T, Broccoli P, Pierangeli S, Bollea MR, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial. Fertil Steril 2007; 88: 1541-1547. [DOI:10.1016/j.fertnstert.2007.01.053]
13. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea (review). Cochrane Database Syst Rev 2001; 2: CD002124. [DOI:10.1002/14651858.CD002124]
14. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 2004; 43: 3-35. [DOI:10.1016/S0163-7827(03)00037-7]
15. Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007; 88: 1505-1533. [DOI:10.1016/j.fertnstert.2007.01.056]
16. Lousse JC, Defre`re S, Colette S, Van Langendonckt A, Donnez J. Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis. Hum Reprod 2010; 25: 734-741. [DOI:10.1093/humrep/dep408]
17. Rizzo MT, Nguyen E, Aldo-Benson M, Lambeau G. Secreted phospholipase A2 induces vascular endothelial cell migration. Blood 2000; 96: 3809-3815.
18. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-821. [DOI:10.1016/S0015-0282(97)81391-X]
19. Noyes RW, Hertig DT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122: 262-263. [DOI:10.1016/S0002-9378(16)33500-1]
20. Bersinger NA, Frischknecht F, Taylor RN, Mueller MD. Basal and cytokine-stimulated production of epithelial neutrophil activating peptide-78 (ENA-78) and interleukin-8 (IL-8) by cultured human endometrial epithelial and stromal cells. Fertil Steril 2008; 89: 1530-1536. [DOI:10.1016/j.fertnstert.2007.05.075]
21. Bruse C, Guan Y, Carlberg M, Carlstrom K, Bergqvist A. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. Fertil Steril 2005; 83: 1155-1560. [DOI:10.1016/j.fertnstert.2004.09.033]
22. Yang Y, Degranpre P, Kharfi A, Akoum A. Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting Agent Released by Ectopic Human Endometrial Cells. J Clin Endocrinol Metab 2000; 85: 4721-4727. [DOI:10.1210/jc.85.12.4721]
23. Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 2010; in Press.
24. Sengupta S, Sengupta J, Mittal S, Kumar S, Ghosh D. Effect of human chorionic gonadotropin(HCG) on expression of vascular endometrial growth factor A (VEGF-A) in human mid-secretory endometrial cells in three-dimentional primary culture. Indian J Physiol Pharmacol 2008; 52: 19-30.
25. Arnold JT, Kaufman DG, Seppala M, Lessey B. Endometrial stromal cells regulate epithelial cell growth in vitro: a new coculture model. Hum Reprod 2001; 16: 836- 845. [DOI:10.1093/humrep/16.5.836]
26. Akoum A, Lawson C, Mccol C, Villeneuve M. Ectopic endometrial cells express of high concentrations of (IL)-8 invivo regardless of the menstrual cycle phase and respond to oestradiol by up regulating IL-1 induced IL-8 expression invitro. Mol Hum Reprod 2001; 7: 859-866. [DOI:10.1093/molehr/7.9.859]
27. Vinatier D, Orazi G, Cosson M, Dufour P. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol 2001; 96: 21-34. [DOI:10.1016/S0301-2115(00)00405-X]
28. Haggarty P, Page K, Abramovich DR, Ashton J, Brown D. Long-chain polyunsaturated fatty acid transport across the perfused human placenta. Placenta 1997; 18: 635-642. [DOI:10.1016/S0143-4004(97)90004-7]
29. Haggarty P, Ashton J, Joynson M, Abramovich DR, Page K. Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biol Neonate 1990; 75: 350-359. [DOI:10.1159/000014115]
30. Sano M, Morishita T, NozakiM, Yokoyama M, Watanabe Y, Nakano H. Elevation of the phospholipase A2 activity in peritoneal fluid cells from women with endometriosis. Fertil Steril 1994; 61: 657-662. [DOI:10.1016/S0015-0282(16)56642-4]
31. Triggiani M, Granata F, Frattini A, Marone G. Activation of human inflammatory cells by secreted phospholipases A2. Biochim Biophys Acta 2006; 1761: 1289-1300. [DOI:10.1016/j.bbalip.2006.07.003]
32. Beck S, Lambeau G, Scholz-Pedretti K, Gelb MH, Janssen MJ, Edwards SH, et al. Potential of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIa expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation. J Biol Chem 2003; 278: 29799-29812. [DOI:10.1074/jbc.M211763200]
33. Meyer MC, Rastogi P, Beckett CS, McHowat J. Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des 2005; 11: 1301-1312. [DOI:10.2174/1381612053507521]
34. Van den Berg JJM, Op den Kamp JAF, Lubin BH, Kupers FA. Conformational changes in oxidized phospholipids and their preferential Hydrolysis by phospholipase A2: A monolayer study. Biochem 1993; 32: 4962-4967. [DOI:10.1021/bi00069a035]
35. Shanti A, Santanam N, Morales AJ, Parthasarathy S, Murphy AA. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril 1999; 71: 1115-1118. [DOI:10.1016/S0015-0282(99)00145-4]
36. Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril 2009; 91: 46-50. [DOI:10.1016/j.fertnstert.2007.11.021]
37. Peilot H, Rosengren B, Bondjers G, Hurt-Camejo E. Interferon-gamma Induces Secretory Group IIA Phospholipase A2 in Human Arterial Smooth Muscle Cells. J Biol Chem 2000; 275: 22895-22904. [DOI:10.1074/jbc.M002783200]
38. Calder PC. Omega 3 Fatty acids and inflammatory processes. Nutrients 2010; 2: 355-374. [DOI:10.3390/nu2030355]
39. Netsu S, Konno R, Odagiri K, Soma M, Fujiwara H, Suzuki M. Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril 2008; 90: 1496-1502. [DOI:10.1016/j.fertnstert.2007.08.014]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb